Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 1;29(6):596-604.
doi: 10.4062/biomolther.2021.122.

Lipid Metabolism, Disorders and Therapeutic Drugs - Review

Vijayakumar Natesan  1 , Sung-Jin Kim  2
Affiliations
Review

Lipid Metabolism, Disorders and Therapeutic Drugs - Review

Vijayakumar Natesan et al. Biomol Ther (Seoul). .

Abstract

Different lifestyles have an impact on useful metabolic functions, causing disorders. Different lipids are involved in the metabolic functions that play various vital roles in the body, such as structural components, storage of energy, in signaling, as biomarkers, in energy metabolism, and as hormones. Inter-related disorders are caused when these functions are affected, like diabetes, cancer, infections, and inflammatory and neurodegenerative conditions in humans. During the Covid-19 period, there has been a lot of focus on the effects of metabolic disorders all over the world. Hence, this review collectively reports on research concerning metabolic disorders, mainly cardiovascular and diabetes mellitus. In addition, drug research in lipid metabolism disorders have also been considered. This review explores lipids, metabolism, lipid metabolism disorders, and drugs used for these disorders.

Keywords: Cardiovascular disorder; Diabetes; Disorders; Drugs; Lipid metabolism.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Classifications of lipid metabolism disorders based on the nature of lipid and factors.
Fig. 2
Fig. 2
Various reasons for cardiovascular disorders by lipids storage related metabolic actions.
Fig. 3
Fig. 3
Methods of controlling lipid disorder.
See this image and copyright information in PMC

References

    1. Ahmed S., Shah P., Ahmed O. StatPearls. StatPearls Publishing; Treasure Island: 2021. Biochemistry, lipids; pp. 11–19. - PubMed
    1. Alves-Bezerra M., Cohen D. E. Triglyceride metabolism in the liver. Compr. Physiol. 2017;8:1–8. doi: 10.1002/cphy.c170012. - DOI - PMC - PubMed
    1. Alwarawrah Y., Hughes P., Loiselle D., Carlson D. A., Darr D. B., Jordan J. L., Xiong J., Hunter L. M., Dubois L. G., Thompson J. W., Kulkarni M. M., Ratcliff A. N., Kwiek J. J., Haystead T. A. Fasnall, a selective FASN inhibitor, shows potent anti-tumor activity in the MMTV-Neu model of HER2(+) breast cancer. Cell Chem. Biol. 2016;23:678–688. doi: 10.1016/j.chembiol.2016.04.011. - DOI - PMC - PubMed
    1. Amalan V., Vijayakumar N. Antihyperglycemic effect of p-coumaric acid on streptozotocin induced diabetic rats. Indian J. Appl. Res. 2015;5:10–13.
    1. Amalan V., Vijayakumar N., Ramakrishnan A. P-Coumaric acid regulates blood glucose and antioxidant levels in streptozotocin induced diabetic rats. J. Chem. Pharm. Res. 2015;7:831–839.

LinkOut - more resources